As the COVID-19 outbreak began to greatly impact our global society, medical companies were forced to rapidly respond – keeping patients at the core of their actions, while being called to develop medical solutions amid a pandemic. We have gained critical takeaways from this topic over the past months, and we would love to share them with you – allowing us to collaboratively fight this global crisis together.
Watch our recent webinar, ‘The New Normal Amid the SARS-CoV-2 Pandemic: Contributions From a High-Complexity Diagnostic Laboratory,’ to learn how CENTOGENE successfully set up a SARS-CoV-2 detection laboratory and overcame the logistics and obstacles of developing a high-throughput, high-quality diagnostic test. Moreover, you will also find out about how multiomic research may be able to unlock the mysteries surrounding COVID-19.
- Lessons from successfully setting up a SARS-CoV-2 laboratory
- Global expansion of SARS-CoV-2 detection testing
- Spearheading multiomic research to unlock the mysteries surrounding COVID-19
Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Genomic Officer, where he combines […]